PRESS RELEASE

Rising prevalence rate of skin and eye diseases anticipated to drive the topical drug delivery market in the forecast period of 2019-2025.

Published Date | 2019 October 31

BlueWeave Consulting review study of the Topical Drug Delivery Market anticipated to propel with a significant CAGR of 5.4% in the forecasted period of 2019-2025. The increasing rate of skin and eye disease prevalence is becoming one of the factors to drive growth in the global topical drug delivery market. The rising trend of skin-related diseases such as psoriasis, cancer, etc. due to changing lifestyle patterns is contributing to an increase in the demand for topical drug delivery in the market with a significant growth rate. Rising alternative modes of drug delivery such as injectable, oral, and pulmonary of the drug delivery care sector are anticipated to hamper the growth of topical drug delivery market in the upcoming years.

Growing prevalence of diabetes expected to dominate the global topical drug delivery market

The increasing rate of disposable income, preference shifts in eating habits are the key factor contributing to diabetes prevalence. The rising rate of diabetes prevalence is the key factor anticipated to drive the growth and demand of topical drug delivery system in the market with eye care segmentation. semi-solid formulation segment is expected to dominate the global topical drug delivery market due to an advantage factor such as easy drug release, patient acceptability, and multiple applications in the upcoming years with the commendable growth rate.

Technological advancement in the homecare setting is the key factor propelling the growth in the market in the forecast period

Technological advancement in the healthcare sector, coupled with increasing healthcare expenditure anticipated to dominate the global market in the upcoming years. Properties such as deep penetration of drugs within the body, preference shift of patient due to non-invasive nature and increasing rate of geriatric population, R&D, biologics delivery via a transdermal route with small player’s acquisition expected to drive the global topical drug delivery market in the upcoming years with a significant growth rate. The market is anticipated to dominate by homecare setting as a homecare setting to eliminate the hospital visit to save patient time and money. The rising affordability and convenience are the key factor expected to propel the growth during the forecast period of 2019-2025.

Topical Drug Delivery Market: competitive landscape

Some of the major industry players are Glaxosmithkline, Janssen Global Services (A Subsidiary of Johnson & Johnson), Bausch Health Companies, Merck & Co., Bayer AG, Hisamitsu Pharmaceutical, Nestlé Sa, Novartis AG, Glenmark Pharmaceuticals, Cipla and Other Prominent Player.

Don’t miss the business opportunity of topical drug delivery Market. Consult to our analyst and gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of nutraceutical products market size & forecast. The report promises to provide state-of-the-art technology of Topical Drug Delivery Market and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

About Us

BlueWeave Consulting is a one-stop solution for market intelligence regarding various products and services online & offline. We offer worldwide market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality performance and nourishing the long-lasting relationships with its clients. We are one of the promising digital market intelligence generation company delivering unique solutions for blooming your business and making the morning, more rising & shining.

Contact Us:

info@blueweaveconsulting.com

https://www.blueweaveconsulting.com

Global Contact: +1 866 658 6826, +1 425 320 4776